Some psychedelic drugs – paired with therapy – hold great potential for helping sufferers of PTSD, depression and other mental health disorders.
The TGA is considering a proposal to reclassify psilocybin and MDMA from their current status as prohibited substances. This would allow psychiatrists to use these drugs to treat mental illness.
The TGA is currently evaluating a proposal to legalise MDMA and psilocybin for the treatment of mental illness. But there are a few reasons Australia isn’t quite ready to take this step.
How on earth did an obscure Roman social practice end up lending its name to a modern psychedelic?
Rather than a vaccine to beef up your immune system, a psychoactive substance could boost your cooperative, pro-social behavior – curtailing the selfish actions that spur on coronavirus’s spread.
Psychedelics can help reset the brain, shaking it out of old patterns. The current state of uncertainty could have similar impacts - a metaphorical psychedelic dose - for new insights.
Australia is about to start its first trial of psychedelic drugs for the treatment of anxiety and depression. If the results are positive, this could transform the way we treat mental illness.
Research shows therapeutic psilocybin to be a safe and effective antidote to end-of-life anxiety and depression. Does prohibition therefore violate our right to “life, liberty and security?”
According to new research, individuals who take small regular doses of psychedelics such as LSD and psilocybin mushrooms score higher on mental health, well-being and creativity.
To know the real promise of psychedelic substances like LSD, mushrooms and MDMA, researchers must embrace the principles and practise of ‘open science.’
Once associated with mind-control experiments and counter-cultural defiance, psychedelics now show great promise for mental health treatments and may prompt a re-evaluation of the scientific method.
Humans have a desire to transcend everyday existence. So laws banning psychoactive substances are on a hiding to nothing.